FindMyKOL
Clinical trialNCT03595605CompletedInterventional

Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition

NCT03595605 is an interventional trial sponsored by NYU Langone Health. As of 21 Nov 2026, it is completed. It studies Physical Medicine. The registry lists an enrollment of 51 participants at 1 site in 1 country. The registry lists a start date of 16 May 2018 and a primary completion date of 30 Mar 2019.

SponsorNYU Langone Health →Enrollment51Physical Medicine
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03595605
FieldValue
Registry IDNCT03595605
StatusCompleted
Study typeInterventional trial
Lead sponsorNYU Langone Health
Enrollment51
Registered sites1
Countries1
ConditionsPhysical Medicine
Start16 May 2018
Primary completion30 Mar 2019
Study completion30 Mar 2019
Last update posted29 May 2020

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will incorporate the use of wearable actigraphy devices (Fitbit) on research participants admitted to medicine inpatient units at Tisch Hospital and/or NYU Brooklyn. The investigator's sample size will be 600 randomized into two groups, with basic inclusion criteria including age greater than 65 years and pre-hospital ambulatory status. While both groups will be monitored in terms of their activity (specifically pedometer data), the intervention group will have twice daily encouragement of ambulation. Once a subject is enrolled, data will be collected daily and at time of discharge.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • New York University School of Medicine

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03595605

Each answer restates registry values shown on this page.

What is NCT03595605?

NCT03595605 is an interventional trial sponsored by NYU Langone Health. It studies Physical Medicine.

Who leads NCT03595605?

The registry names Gavriil Ilizarov (principal investigator, NYU Langone Health) as the overall official.

Where does NCT03595605 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT03595605 end?

The registry lists a primary completion date of 30 Mar 2019 and a study completion date of 30 Mar 2019. The sponsor last updated the record on 29 May 2020.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.